Viewing Study NCT06895928


Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-01-01 @ 2:28 AM
Study NCT ID: NCT06895928
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2025-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module